Clinical Trials Logo
  1. Home
  2. Colon Cancer Screening
  3. NCT03775473
  4. Details
NCT03775473 Clinical Trial

PROgastrine COlon DEpistage

Colon Cancer Screening Clinical Trial

Official title:
Dosage of Progastrin in Asymptomatic Person Participating in Colon Cancer Screening

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT03775473
Other study ID # PROCODE
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date February 7, 2019
Est. completion date December 17, 2021

Study information
Verified date January 2022
Source ECS-Progastrin SA
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Dosage of progastrin in asymptomatic person participating in colon cancer screening

Description:

For anyone who will participate in colon screening at the Princess Grace Hospital of Monaco and who has signed the informed consent document. A blood test will be performed in addition to the screening test to assess the rate of progastrin.

Recruitment information / eligibility
Status Terminated
Enrollment 260
Est. completion date December 17, 2021
Est. primary completion date February 5, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria: - participant in colon cancer screening - signing informed consent Exclusion Criteria: - any major medical, psychiatric or addictive illness that would affect the informed consent process - The consent of a representative is not allowed in this study

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• progastrin
PROCODE is an interventional study of category 2 (non-medicinal product), with a minimal risks and restrictions, involving only one blood drawn at the screening of colon cancer.

Locations
Country Name City State
France Centre Hospitalier Princesse Grace, Monaco Montpellier MC

Sponsors (2)
Lead Sponsor Collaborator
ECS-Progastrin SA Centre Hospitalier Princesse Grace

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary progastrin rate measuring the rate of progastrin in the blood from 15 days to 2 months (until results are obtained)
See also
  Status Clinical Trial Phase
Completed NCT04601272 - Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions
Unknown status NCT01704820 - Right Sided Colon Polyp Miss Rate: Impact Of Retroflexion In The Right Colon N/A
Enrolling by invitation NCT06116864 - Enchasing Polyp Detection: The Effect of Adding Polyp Detection Attachment Device to Computer Aid Detection System. N/A
Completed NCT00417001 - Reduction of Conscious Sedation Requirements by Olfactory Stimulation N/A
Active, not recruiting NCT03735953 - Retroflexion in the Entire Colon for the Detection of Colon-related Diseases N/A
Completed NCT04491565 - An Interactive Video Educational Tool Improves the Quality of Bowel Preparation for Colonoscopy N/A
Recruiting NCT05793593 - A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer N/A
Completed NCT01648504 - Johns Hopkins Interactive eGuide to Colonoscopy and Ipad Office Education to Improve Colonoscopy N/A
Completed NCT01411826 - Online Programs to Promote Colon Cancer Screening N/A
Completed NCT02665741 - Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope Attachments N/A
Recruiting NCT04651504 - Rural Colon Cancer Screening Toolkit Intervention N/A
Completed NCT00719641 - Experimental Device to Improve Colonoscopy